Spectrum Dynamics Medical Veritas.AI FDA Clearance
Analysis based on 10 articles · First reported Jan 29, 2026 · Last updated Jan 29, 2026
The FDA clearance for Veritas.AI by Spectrum Dynamics Medical is expected to positively impact the medical imaging market by introducing an advanced AI-powered solution. This could lead to increased adoption of digital SPECT/CT systems, improving diagnostic accuracy and operational efficiency in nuclear medicine.
Spectrum Dynamics Medical, a leader in digital nuclear medicine imaging, announced it received FDA 510(k) clearance for Veritas.AI Noise Reduction. This advanced artificial intelligence platform is designed to enhance image quality, diagnostic confidence, and operational efficiency on the VERITON-CT digital SPECT/CT system. Veritas.AI leverages a deep learning convolutional neural network to reduce image noise while preserving spatial resolution and quantitative accuracy. The technology is clinically validated across various applications, including bone imaging, Lu-177 theranostics, and I-123 MIBG. It can decrease scanning times by up to 50%, improving patient comfort and department throughput. The Veritas.AI suite includes specialized applications like Bone-IQ.AI, Thera-IQ.AI, and MIBG-IQ.AI, each optimized for specific clinical needs. Tomer Gabay, CEO of Spectrum Dynamics Medical, emphasized the significance of this milestone for the company and the nuclear medicine community, highlighting its commitment to precision imaging and AI-driven innovation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard